348 related articles for article (PubMed ID: 33388882)
1. Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases.
Hu C; Zhao L; Li L
J Mol Med (Berl); 2021 Feb; 99(2):179-192. PubMed ID: 33388882
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases.
Hu C; Wu Z; Li L
J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases.
Liu P; Yao L; Hu X; Wang Z; Xiong Z; Jiang Y
J Gastroenterol Hepatol; 2023 Jul; 38(7):1099-1106. PubMed ID: 37271943
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury.
Hu C; Zhao L; Zhang L; Bao Q; Li L
Stem Cell Res Ther; 2020 Sep; 11(1):377. PubMed ID: 32883343
[TBL] [Abstract][Full Text] [Related]
5. Effects of Extracellular Vesicles Derived from Mesenchymal Stem/Stromal Cells on Liver Diseases.
Zheng W; Yang Y; Sequeira RC; Bishop CE; Atala A; Gu Z; Zhao W
Curr Stem Cell Res Ther; 2019; 14(5):442-452. PubMed ID: 30854976
[TBL] [Abstract][Full Text] [Related]
6. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.
Liu WH; Song FQ; Ren LN; Guo WQ; Wang T; Feng YX; Tang LJ; Li K
J Cell Mol Med; 2015 Mar; 19(3):511-20. PubMed ID: 25534251
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cell therapy for liver diseases.
Alfaifi M; Eom YW; Newsome PN; Baik SK
J Hepatol; 2018 Jun; 68(6):1272-1285. PubMed ID: 29425678
[TBL] [Abstract][Full Text] [Related]
8. Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases.
Lin H; Xu R; Zhang Z; Chen L; Shi M; Wang FS
Cell Mol Immunol; 2011 Jan; 8(1):19-22. PubMed ID: 21200380
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell homing to improve therapeutic efficacy in liver disease.
Yuan M; Hu X; Yao L; Jiang Y; Li L
Stem Cell Res Ther; 2022 May; 13(1):179. PubMed ID: 35505419
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis.
Liu P; Qian Y; Liu X; Zhu X; Zhang X; Lv Y; Xiang J
Front Immunol; 2022; 13():1096402. PubMed ID: 36685534
[TBL] [Abstract][Full Text] [Related]
11. The potential role of genetically-modified pig mesenchymal stromal cells in xenotransplantation.
Li J; Ezzelarab MB; Ayares D; Cooper DK
Stem Cell Rev Rep; 2014 Feb; 10(1):79-85. PubMed ID: 24142483
[TBL] [Abstract][Full Text] [Related]
12. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism.
Planat-Benard V; Varin A; Casteilla L
Front Immunol; 2021; 12():626755. PubMed ID: 33995350
[TBL] [Abstract][Full Text] [Related]
13. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
[TBL] [Abstract][Full Text] [Related]
14. Liver Disease and Cell Therapy: Advances Made and Remaining Challenges.
Khan S; Mahgoub S; Fallatah N; Lalor PF; Newsome PN
Stem Cells; 2023 Aug; 41(8):739-761. PubMed ID: 37052348
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis.
Kim MD; Kim SS; Cha HY; Jang SH; Chang DY; Kim W; Suh-Kim H; Lee JH
Exp Mol Med; 2014 Aug; 46(8):e110. PubMed ID: 25145391
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of mesenchymal stem cells in liver injury.
Puglisi MA; Tesori V; Lattanzi W; Piscaglia AC; Gasbarrini GB; D'Ugo DM; Gasbarrini A
J Biomed Biotechnol; 2011; 2011():860578. PubMed ID: 22228987
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells for inflammatory airway disorders: promises and challenges.
Fan XL; Zhang Z; Ma CY; Fu QL
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610158
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin-Modified Mesenchymal Stem Cells Enhance Anti-fibrosis Efficacy in Mouse Liver Fibrosis Model.
Wang X; Wang H; Lu J; Feng Z; Liu Z; Song H; Wang H; Zhou Y; Xu J
Tissue Eng Regen Med; 2020 Oct; 17(5):683-693. PubMed ID: 32621283
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells promote liver regeneration through regulation of immune cells.
Hu C; Wu Z; Li L
Int J Biol Sci; 2020; 16(5):893-903. PubMed ID: 32071558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
